Clinical Trials for Urinary Bladder Neoplasm

Find clinical trials for urinary bladder neoplasm. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT ID: NCT06465069

This clinical trial is studying a new drug called LY4052031 to see if it is safe and effective for patients with advanced or metastatic solid tumors, including types of bladder, breast, lung, and p...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, New York, New York, United States +36 more

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

NCT ID: NCT04442724

This clinical trial is investigating a new way to improve treatment for bladder cancer. Researchers want to see if placing tiny gold markers around the tumor can help doctors accurately find the tu...

Recruiting

Phase: NA Type: interventional Locations: Los Angeles, California, United States, Los Angeles, California, United States +1 more

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

NCT ID: NCT06238479

This clinical trial is investigating a new drug called LY4101174 to see if it is safe and effective for people with advanced solid tumors that have come back or spread to other parts of the body. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Boston, Massachusetts, United States +34 more

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

NCT ID: NCT05786716

The DETERMINE Trial is investigating whether a combination of two cancer-fighting drugs, trastuzumab and pertuzumab, can help patients with various types of cancers that have specific changes in th...

Recruiting

Phase: PHASE2 Type: interventional Locations: London, , United Kingdom, Leeds, , United Kingdom +27 more

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

NCT ID: NCT06237920

This clinical trial is looking at new treatment options for patients with Stage II-IIIa urothelial cancer, which is a type of bladder cancer. The study is comparing two treatment approaches: one gr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Utrecht, , Netherlands, Amsterdam, Noord Holland, Netherlands +5 more

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

NCT ID: NCT04561362

This clinical trial is studying a new treatment called BT8009 for patients with advanced solid tumors, particularly those that express a protein called Nectin-4. The trial is open to adults aged 65...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bordeaux, , France, Lyon, , France +33 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions